Jumping the shark by Petsko, Gregory A
Genome Biology 2007, 8:101
Comment
Jumping the shark
Gregory A Petsko
Address: Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, MA 02454-9110, USA. 
Email: petsko@brandeis.edu
Published: 31 January 2007
Genome Biology 2007, 8:101 (doi:10.1186/gb-2007-8-1-101)
The electronic version of this article is the complete one and can be
found online at http://genomebiology.com/2007/8/1/101
© 2007 BioMed Central Ltd 
Popular culture, I've long believed, is the best way of finding
out what most people care about at any point in time. That's
the reason I have no patience with those who disdain watch-
ing television and refuse to even have one in their homes. By
ignoring such a pervasive cultural reference point, they are
distancing themselves from much of the rest of humanity.
I'm not demanding that they watch television constantly, or
even very often, but if they never look at it at all, they will
never understand what most of those around them are
seeing and talking about. I think most television programs
are drivel, but I try to know at least a little bit about the most
popular ones so that I feel somewhat connected to my
culture. The same goes for mass-market movies and
'popular' literature such as detective fiction. 
Besides, without popular culture, where would we get some of
our most useful metaphors? Speaking metaphorically can
itself be distancing, of course, if the listener doesn't under-
stand the reference, but when the metaphors are drawn from
popular culture that tends to be less likely. The problem with
such metaphors is that they rapidly become stale and hack-
neyed, but even the more clichéd ones have the benefit of
making conversation and writing more colorful than it other-
wise would be in this age of technobabble and political cor-
rectness. Examples include 'drink the Koolaid', meaning to
accept something blindly that an authority figure tells you - a
reference to the 1978 mass murder/suicide by poisoned fruit
drink in Jonestown, Guyana.
My personal favorite is 'jumping the shark'. It was first
used to describe that time when a long-running television
program begins to decline in both creative energy and
ratings, and then tries all manner of gimmicks in an
increasingly desperate attempt to hold on to its viewers. In
so doing, it strays even further from the qualities that made
it successful in the first place. The specific reference is to
the low-brow situation comedy 'Happy Days', which con-
cerned a group of teenagers in a typical 1950s suburban
American community. In addition to the stereotypical
popular kid, goofy kid and musically talented kid, the show
featured one Arthur 'The Fonz' Fonzarelli, played by Henry
Winkler: a leather-jacketed, tough-talking, basically kind-
hearted, motorcycle-riding dropout - sort of a toned-down
version of the Marlon Brando character in the movie 'The
Wild One'. For those of you not old enough to remember
the thin, pre-Godfather Brando, virtually the same charac-
ter type appears as the male lead in the musical 'Grease' (in
the film of which, the part is played by John Travolta).
'Happy Days' ran for 11 years, far longer than its rather
silly plots and thin characterizations could support, and as
viewers dropped off the show turned to increasingly pre-
posterous storylines, most of which featured The Fonz in
bizarre, out-of-character situations. The apex - or perhaps
nadir would be a better word - of this nonsense was the
famous (infamous?) jumping the shark episode, in which
The Fonz, still clad in his trademark leather jacket but
wearing a swimsuit and lifebelt that even John Travolta
would never be caught dead in, waterskied around a lagoon
housing a man-eating shark, over which he jumped in the
climax - if that word can be used to describe something like
this - of the show. (If you don't believe me, and I don't
blame you if you don't, you can watch the video clip online
[http://www.ifilm.com/ifilmdetail/2666632]) The whole
business was so monumentally stupid that it soon gave rise
to the expression 'jumping the shark': that moment when a
show, desperate for new ideas, tries ones that are so ridicu-
lous that it fails to remain true to itself. 
Over the years most long-running TV programs have
jumped the shark in their quest to maintain their ratings. A
precious few, in my opinion, never did, and so hold a special
place in the annals of popular culture. (My list would
include 'WKRP in Cincinnati', 'The Mary Tyler Moore
Show', and 'The Phil Silvers Show'; there's a website
[http://www.jumptheshark.com/] in which fans of various
programs debate - endlessly, it would seem - whether a par-
ticular program did or did not jump, and if so, exactly when
and how it did.) Gradually, the phrase has crept - slithered? -
into the lexicon as a general metaphor for losing one's core
values in a quest for popularity or profits. The recent proposal by the Bush Administration to send more
US troops into Iraq could be cited as evidence that they, too,
have jumped the shark, if the only 'new' idea they could think
of was to repeat the old one that didn't work. In this case, it's
votes, not ratings, that they are angling for, but the principle is
the same. Personally, I think they actually jumped several
years ago, when they decided to invade Iraq in the first place.
And that unforgettable image of the President on the aircraft
carrier, in full flight regalia, with the 'Mission Accomplished'
sign behind him, reminds me a lot of The Fonz in his leather
jacket and swimsuit.
Such pandering - or is it prostituting? - isn't the exclusive
province of television and political leaders, of course,
although they may have perfected it. For an example more
familiar to the readers of this column, consider the journals
Nature and Cell. Both were wildly successful, general-content
scientific journals whose very names became synonymous
with high-quality, high-impact papers. Then came Nature
Structural and Molecular Biology, Nature Medicine, Nature
Immunology, Nature Genetics, Nature Chemical Biology,
Mother Nature - OK, I made that last one up, but give the
folks at MacMillan publishers time. Not to be outdone, Cell
rapidly metastasized into Molecular Cell,  Developmental
Cell, Cancer Cell, Cell Metabolism, Cell Phone, and so on. To
be sure, these are all high-profile journals that still publish
good papers (I'd like to publish in them someday, so I have to
say that) but can there be any doubt that the brand has been
diluted at least somewhat by this proliferation? And since
both families of journal are published as for-profit enter-
prises, it's hard to escape the conclusion that the primary
motive behind the fission was the profit motive, and, there-
fore, that they've jumped the shark. (Their main rival for the
title of Most Important Place to Publish, Science, is published
by a non-profit scientific society, which may explain why it
hasn't jumped. At least not yet.) 
Which brings me to the point of this column (I bet you were
starting to wonder if it had one, weren't you?): with the
advent of genomics, has biology jumped the shark? You
could make the case that genomics was born on waterskis
with a Great White swimming below, because its values
seem to be so at odds with what were once considered the
core values of the life sciences. Instead of emphasizing
hypothesis-driven, investigator-initiated inquiry, genomics
focuses on large scale data gathering and analysis, usually
done by big teams. Biology used to be thought of as low-tech;
genomics is technology-oriented. So does the advent of
genomics mean that biology has run out of good ideas, and is
desperately hoping that data mining will produce some? 
Ostensibly, the answer is no. Genomics was sold to the sci-
entific community as big science in the service of small
science. The argument was that systematic data gathering
would provide the bases for countless new, hypothesis-
driven experiments. To some extent, it has done just that,
but there's a catch: the pool of available research dollars is
relatively fixed, and money that funds genomics projects
isn't available to fund those hypothesis-driven experiments,
so their number is bound to go down. I think that tension
between the two modes of biology research will work itself
out, but until it does there will continue to be fears that
genomics marks a transition away from the core values of
the subject.
The real danger, it seems to me, is when some sub-discipline
attempts to change its values to reflect those of genomics
without considering the consequences to its intellectual
health. That is exactly what has happened to structural
biology. When a cadre of structural biologists sold the idea of
structural genomics to the funding agencies, I think they
jumped the shark. In the very early days of structural
biology, when we had no idea what the universe of protein
folds looked like, every new structure was interesting for its
own sake, as a glimpse into a largely unknown world. It
didn't matter what the protein did, if it was a 'new' structure
it was important. But that excitement had largely faded at
least 15 years ago, when it was pretty clear that we had seen
most of the major fold classes and anyway they were all
pretty much variations on similar themes. Then the function
of the protein became the benchmark for the importance of
its structure, and the best structural biology combined struc-
ture determination with functional insights and biological
experiments. That was the core value of the discipline until,
in an attempt to secure funding for routine structure deter-
mination, structural biologists tried to piggyback on the
success of the Human Genome Project with a proposal to
fund a set of consortia whose mission was to determine
either the structures of a representative example of every
protein fold, or the structures of all proteins in a particular
genome. Such assembly-line crystallography (or nuclear
magnetic resonance (NMR), in some cases) has started to
produce a lot of structures, but I think almost no one cares.
The goal of filling in the fold catalog was quickly abandoned,
not only because it was too difficult but also because it was
certainly true that no one except perhaps a few bioinformati-
cists cared.  And the goal of determining all the structures in
a genome also proved to be too difficult: the thing about
high-throughput crank-turning is that it can't afford to stop
to wrestle with difficult problems, and of course the most
interesting proteins often seem to be the ones that are most
difficult to express in a heterologous organism, then purify,
and crystallize. Thus, the structural genomics initiative has,
up to now, concentrated on the low-hanging fruit (one may
say, in some cases, the fruit that has already fallen to the
ground). And what do we have as a value system for the field
now? Is it to churn out structures regardless of their impor-
tance? Is it to be a service for the drug companies and cell
biologists, who will dictate what is important and reap the
rewards from studying function and exploiting structure
themselves? It certainly seems as though that's where things
are heading, and if I'm right, I think future historians of
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moment when structural biology put on its life belt and
swimsuit and headed out over the shark pool. 
It doesn't have to be that way. Fields should be able to make
use of genomic information without attempting to absorb
the ethos of big, data-gathering-science. If they can do that,
then genomics will be an enabling technological revolution,
which helps propel a lot of non-data gathering science
forward. But if a field tries to become like genomics when it
really is something very different, then it jumps the shark.
Like a television program past its prime, if it thinks - or fears
- that it has run out of good ideas, it will try bad ones. It will
go backwards, not forwards. And when that happens, like
the shark itself, which must constantly swim forwards to
survive, it will begin to die. 
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